Americafirst Capital Management buys $2,006,004 stake in MEDNAX Inc (MD)

MEDNAX Inc (MD) : Americafirst Capital Management scooped up 2,166 additional shares in MEDNAX Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 18, 2016. The investment management firm now holds a total of 26,704 shares of MEDNAX Inc which is valued at $2,006,004.MEDNAX Inc makes up approximately 1.38% of Americafirst Capital Management’s portfolio.

Other Hedge Funds, Including , Trust Co Of Vermont added MD to its portfolio by purchasing 150 company shares during the most recent quarter which is valued at $11,268. Sarasin Partners Llp sold out all of its stake in MD during the most recent quarter. The investment firm sold 17,600 shares of MD which is valued $1,317,888.Creative Planning boosted its stake in MD in the latest quarter, The investment management firm added 52 additional shares and now holds a total of 517 shares of MEDNAX Inc which is valued at $39,354.Gw&k Investment Management reduced its stake in MD by selling 63,025 shares or 19.7% in the most recent quarter. The Hedge Fund company now holds 256,864 shares of MD which is valued at $19,552,488. MEDNAX Inc makes up approx 0.40% of Gw&k Investment Management’s portfolio.

MEDNAX Inc opened for trading at $75.09 and hit $75.215 on the upside on Wednesday, eventually ending the session at $75.12, with a gain of 0.59% or 0.44 points. The heightened volatility saw the trading volume jump to 3,52,193 shares. Company has a market cap of $6,988 M.

On the company’s financial health, MEDNAX Inc reported $0.87 EPS for the quarter, based on the information available during the earnings call on Apr 28, 2016. Analyst had a consensus estimate of $0.87. The company had revenue of $752.60 million for the quarter, compared to analysts expectations of $741.00 million. The company’s revenue was up 17.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.72 EPS.

Many Wall Street Analysts have commented on MEDNAX Inc. Company shares were Reiterated by Mizuho on Apr 29, 2016 to “Buy”, Firm has raised the Price Target to $ 79 from a previous price target of $75 .

MEDNAX Inc. (MEDNAX) is a provider of physician services including newborn maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists such as pediatric intensivists pediatric hospitalists and pediatric surgeons.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

MEDNAX Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on MEDNAX Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.